GSK Aktie
20,10
EUR
-0,39
EUR
-1,90
%
17,84
GBP
-0,27
GBP
-1,46
%
Werbung
GSK Aktie Analyse
| 23.07.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.07.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 16.07.18 | GSK Neutral | Credit Suisse Group | |
| 13.07.18 | GSK Neutral | Credit Suisse Group | |
| 10.07.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.07.18 | GSK Hold | Deutsche Bank AG | |
| 03.07.18 | GSK neutral | Deutsche Bank AG | |
| 20.06.18 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.05.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.04.18 | GSK Hold | Deutsche Bank AG | |
| 26.04.18 | GSK Hold | Kepler Cheuvreux | |
| 26.04.18 | GSK Hold | Deutsche Bank AG | |
| 09.04.18 | GSK Hold | Deutsche Bank AG | |
| 28.03.18 | GSK Equal-Weight | Morgan Stanley | |
| 28.03.18 | GSK Hold | Kepler Cheuvreux | |
| 28.03.18 | GSK Hold | Deutsche Bank AG | |
| 23.03.18 | GSK Hold | Deutsche Bank AG | |
| 22.03.18 | GSK Equal-Weight | Morgan Stanley | |
| 12.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.18 | GSK Hold | Deutsche Bank AG | |
| 09.02.18 | GSK Hold | Kepler Cheuvreux | |
| 08.02.18 | GSK Hold | Deutsche Bank AG | |
| 08.02.18 | GSK market-perform | Bernstein Research | |
| 08.02.18 | GSK Neutral | Credit Suisse Group | |
| 08.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.02.18 | GSK market-perform | Bernstein Research | |
| 05.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.01.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.01.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.01.18 | GSK Hold | Deutsche Bank AG | |
| 11.01.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.12.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.12.17 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 30.11.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.17 | GSK Hold | Deutsche Bank AG | |
| 27.10.17 | GSK Equal weight | Barclays Capital | |
| 27.10.17 | GSK neutral | JP Morgan Chase & Co. | |
| 26.10.17 | GSK Neutral | Merrill Lynch & Co., Inc. | |
| 26.10.17 | GSK Neutral | UBS AG | |
| 26.10.17 | GSK Hold | Deutsche Bank AG | |
| 26.10.17 | GSK Hold | S&P Capital IQ | |
| 25.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | GSK Neutral | UBS AG | |
| 23.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.10.17 | GSK Hold | Deutsche Bank AG | |
| 10.10.17 | GSK Neutral | UBS AG | |
| 02.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung